Gary S. Jacob
Chief Executive Officer, CALLISTO PHARMACEUTICALS INC.
Companies
- OKYO Pharma LtdChief Development Officer Mar 18, 2026 to now1
- OKYO Pharma LtdBoard member May 16, 2022 to now2
- Hepion Pharmaceuticals, Inc.Board member Oct 7, 2013 to Feb 21, 20243
- OKYO Pharma LtdChief executive officer May 16, 2022 to May 19, 20222
- Virpax Pharmaceuticals, Inc.Board member Feb 16, 2021 to Jan 5, 20224
- Cardiff Oncology, Inc.Board member Jan 24, 2012 to Mar 23, 20215
- Hepion Pharmaceuticals, Inc.Chief executive officer Oct 7, 2013 to Feb 20, 20143
- Hepion Pharmaceuticals, Inc.President Oct 7, 2013 to Feb 20, 20143
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- OKYO Pharma Ltd OKYO112,420 shares6$157.4K at $1.40Jul 21, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 21, 2026Bought 3,500 shares at $1.40 of OKYO Pharma Ltd6
- Jul 21, 2026Granted 3,500 shares at $1.40 of OKYO Pharma Ltd7
- May 19, 2022Bought 12,500 shares at $4.00 of OKYO Pharma Ltd8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGAROKYO Pharma Ltd, Board member
- 3
- 4
- 5SEC EDGARCardiff Oncology, Inc., Board member
- 6
- 7SEC EDGARForm 4 filed Jul 23, 2026
- 8SEC EDGARForm 4 filed May 19, 2022